Global Medical REIT Inc (NYSE:GMRE) was downgraded by equities research analysts at Compass Point from a “buy” rating to a “neutral” rating in a note issued to investors on Tuesday.

Separately, DA Davidson reiterated a “buy” rating on shares of Global Medical REIT in a research note on Monday, July 25th.

Shares of Global Medical REIT (NYSE:GMRE) traded down 2.97% during trading on Tuesday, reaching $10.12. 76,662 shares of the company traded hands. The stock’s 50 day moving average is $10.62 and its 200 day moving average is $10.55. The company’s market capitalization is $178.16 million. Global Medical REIT has a 1-year low of $9.52 and a 1-year high of $11.38.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/global-medical-reit-inc-gmre-downgraded-to-neutral-at-compass-point.html

Global Medical REIT Company Profile

5 Day Chart for NYSE:GMRE

Receive News & Ratings for Global Medical REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc and related companies with MarketBeat.com's FREE daily email newsletter.